Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Dilated Cardiomyopathy
NCT06632834Phase 2Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2020
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in dilated cardiomyopathy (DCM), sponsored by National Taiwan University Hospital. Primary endpoints: Left Ventricular Ejection Fraction at 2 years and N-terminal pro-brain natriuretic peptide at 2 years. Started Aug 2020; status: recruiting.
02
Drugs
simvastatin
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT06632834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06632834.